Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Pills-in-the-Pocket Strategy for Recurrent AF
NCT06657404Recruiting
- Start
- Oct 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of amiodarone in Atrial fibrillation (AFib). Primary endpoint: Converted to Sinus Rhythm at 1 month. Started Oct 2024; status: recruiting.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06657404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06657404.